Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03323502 · ClinicalTrials.gov registry record · NA

Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support

A NA study of Alzheimer Disease and Dementia, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
47,396
Enrollment target
2
Study locations

NCT03323502 is a NA study of Alzheimer Disease and Dementia that has completed, run by Indiana University. The registered enrollment target is 47,396 participants, above the 2,596-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (1726% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03323502, a NA study of Alzheimer Disease and Dementia, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
47,396 participants
Enrollment target
2
Study locations

Study Summary

Nursing home (NH) patients with Alzheimer's disease and related dementias often receive unwanted, burdensome treatments such as hospitalization. Advance care planning (ACP) is a key strategy to support patients and family-caregivers in making informed decisions and ensuring treatment preferences are proactively known and honored. The ACP Specialist Program will improve care and reduce unwanted, burdensome hospitalizations through improved ACP procedures, standardized staff education on ACP, and systematic ACP facilitation delivered by existing NH staff.

Interventions

  • OTHER Standard of care
  • BEHAVIORAL APPROACHES ACP Specialist Program

Study Locations (2)

Indiana

  • Miller's Merry Manor - Warsaw

Kentucky

  • Signature HealthCARE LLC - Louisville

Trial Details

FieldValue
Enrollment Target 47,396 participants
Start Date 2020-02-01
Est. Completion 2022-08-31
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT03323502

The ClinicalTrials.gov registry entry for NCT03323502 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47,396 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,596-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (1726% higher). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.

NCT03323502 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Kentucky.

Frequently Asked Questions

What is clinical trial NCT03323502 about?

NCT03323502 is a clinical study titled "Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support". Nursing home (NH) patients with Alzheimer's disease and related dementias often receive unwanted, burdensome treatments such as hospitalization. Advance care planning (ACP) is a key strategy to support patients and family-caregivers in making informed decisions and ensuring treatment preferences are...

What is the current status of trial NCT03323502?

This trial is currently completed. It is a NA study. The enrollment target is 47,396 participants. The study started on 2020-02-01. Estimated completion is 2022-08-31.

What conditions does trial NCT03323502 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia.

What interventions are being tested in trial NCT03323502?

The interventions under investigation include: Standard of care (OTHER), APPROACHES ACP Specialist Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03323502?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03323502 being conducted?

This trial has 2 study locations across Indiana, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.